Do analysts rate HSIC or PINC?

Henry Schein presently has a consensus target price of $93.57, suggesting a potential upside of 8.63%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Premier. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Henry Schein 1 Sell rating(s) 5 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.50 Premier 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation & earnings, HSIC or PINC?

Henry Schein has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Henry Schein $13.18B 0.72 $398M $3.65 23.60 Premier $1.00B 4.03 $20.27M -$0.27 N/A

Is HSIC or PINC more profitable?

Henry Schein has a net margin of 3.07% compared to Premier's net margin of -3.28%. Henry Schein's return on equity of 16.39% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Henry Schein 3.07% 16.39% 5.58% Premier -3.28% 6.84% 3.48%

Do analysts recommend HQY or PINC?

HealthEquity presently has a consensus price target of $113.53, suggesting a potential upside of 10.17%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Premier. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HealthEquity 1 Sell rating(s) 0 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.92 Premier 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings & valuation, HQY or PINC?

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio HealthEquity $1.31B 6.49 $215.20M $2.77 37.20 Premier $1.00B 4.03 $20.27M -$0.27 N/A

Is HQY or PINC more profitable?

HealthEquity has a net margin of 17.36% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 15.33% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets HealthEquity 17.36% 15.33% 9.51% Premier -3.28% 6.84% 3.48%

Does the media favor HQY or PINC?

In the previous week, HealthEquity had 1 more articles in the media than Premier. MarketBeat recorded 3 mentions for HealthEquity and 2 mentions for Premier. HealthEquity's average media sentiment score of 0.97 beat Premier's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HealthEquity 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Premier 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer PACS or PINC?

PACS Group currently has a consensus target price of $61.33, suggesting a potential upside of 27.30%. Given PACS Group's stronger consensus rating and higher possible upside, equities analysts clearly believe PACS Group is more favorable than Premier. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PACS Group 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Premier 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation & earnings, PACS or PINC?

PACS Group has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio PACS Group $5.29B 1.45 $191.54M $1.77 27.22 Premier $1.00B 4.03 $20.27M -$0.27 N/A

Is PACS or PINC more profitable?

PACS Group has a net margin of 4.87% compared to Premier's net margin of -3.28%. PACS Group's return on equity of 31.98% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets PACS Group 4.87% 31.98% 6.07% Premier -3.28% 6.84% 3.48%

Does the media favor PACS or PINC?

In the previous week, PACS Group had 15 more articles in the media than Premier. MarketBeat recorded 17 mentions for PACS Group and 2 mentions for Premier. PACS Group's average media sentiment score of 0.51 beat Premier's score of 0.00 indicating that PACS Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PACS Group 6 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Premier 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts prefer CHE or PINC?

Chemed currently has a consensus target price of $603.00, indicating a potential upside of 9.79%. Given Chemed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Chemed is more favorable than Premier. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemed 0 Sell rating(s) 4 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.43 Premier 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher earnings and valuation, CHE or PINC?

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Chemed $2.53B 2.83 $265.24M $20.90 26.28 Premier $1.00B 4.03 $20.27M -$0.27 N/A

Is CHE or PINC more profitable?

Chemed has a net margin of 10.61% compared to Premier's net margin of -3.28%. Chemed's return on equity of 35.18% beat Premier's return on equity. Company Net Margins Return on Equity Return on Assets Chemed 10.61% 35.18% 19.43% Premier -3.28% 6.84% 3.48%

Does the media prefer CHE or PINC?

In the previous week, Chemed had 7 more articles in the media than Premier. MarketBeat recorded 9 mentions for Chemed and 2 mentions for Premier. Chemed's average media sentiment score of 0.77 beat Premier's score of 0.00 indicating that Chemed is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemed 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Premier 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate PINC or HIMS?

Hims & Hers Health has a consensus price target of $31.53, suggesting a potential upside of 59.59%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Premier. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Premier 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Hims & Hers Health 1 Sell rating(s) 12 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.13

Does the media prefer PINC or HIMS?

In the previous week, Hims & Hers Health had 69 more articles in the media than Premier. MarketBeat recorded 71 mentions for Hims & Hers Health and 2 mentions for Premier. Premier's average media sentiment score of 0.00 beat Hims & Hers Health's score of -0.19 indicating that Premier is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Premier 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Hims & Hers Health 4 Very Positive mention(s) 13 Positive mention(s) 23 Neutral mention(s) 23 Negative mention(s) 2 Very Negative mention(s) Neutral

This company has been marked as potentially delisted and may not be actively trading.

Premier (PINC) Competitors

Compare

PINC vs. HSIC, HQY, PACS, CHE, and HIMS

Should you buy Premier stock or one of its competitors? Premier's main competitors and comparable companies include Henry Schein (HSIC), HealthEquity (HQY), PACS Group (PACS), Chemed (CHE), and Hims & Hers Health (HIMS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare providers & services" industry.

How does Premier compare to Henry Schein?

Henry Schein (NASDAQ:HSIC) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

In the previous week, Premier had 1 more articles in the media than Henry Schein. MarketBeat recorded 2 mentions for Premier and 1 mentions for Henry Schein. Henry Schein's average media sentiment score of 0.77 beat Premier's score of 0.00 indicating that Henry Schein is being referred to more favorably in the media.

Company	Overall Sentiment
Henry Schein	Positive
Premier	Neutral

Henry Schein has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Henry Schein, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Henry Schein	$13.18B	0.72	$398M	$3.65	23.60
Premier	$1.00B	4.03	$20.27M	-$0.27	N/A

Henry Schein has a beta of 0.87, suggesting that its share price is 13% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

96.6% of Henry Schein shares are owned by institutional investors. Comparatively, 74.4% of Premier shares are owned by institutional investors. 0.9% of Henry Schein shares are owned by insiders. Comparatively, 1.0% of Premier shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Henry Schein has a net margin of 3.07% compared to Premier's net margin of -3.28%. Henry Schein's return on equity of 16.39% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Henry Schein	3.07%	16.39%	5.58%
Premier	-3.28%	6.84%	3.48%

Henry Schein presently has a consensus target price of $93.57, suggesting a potential upside of 8.63%. Given Henry Schein's stronger consensus rating and higher probable upside, analysts plainly believe Henry Schein is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Henry Schein	1 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.50
Premier	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Henry Schein beats Premier on 13 of the 16 factors compared between the two stocks.

How does Premier compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, risk, institutional ownership, valuation, earnings and analyst recommendations.

99.6% of HealthEquity shares are owned by institutional investors. Comparatively, 74.4% of Premier shares are owned by institutional investors. 1.6% of HealthEquity shares are owned by company insiders. Comparatively, 1.0% of Premier shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

HealthEquity has a net margin of 17.36% compared to Premier's net margin of -3.28%. HealthEquity's return on equity of 15.33% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HealthEquity	17.36%	15.33%	9.51%
Premier	-3.28%	6.84%	3.48%

HealthEquity has a beta of 0.22, meaning that its stock price is 78% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

In the previous week, HealthEquity had 1 more articles in the media than Premier. MarketBeat recorded 3 mentions for HealthEquity and 2 mentions for Premier. HealthEquity's average media sentiment score of 0.97 beat Premier's score of 0.00 indicating that HealthEquity is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HealthEquity	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Premier	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HealthEquity has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HealthEquity	$1.31B	6.49	$215.20M	$2.77	37.20
Premier	$1.00B	4.03	$20.27M	-$0.27	N/A

HealthEquity presently has a consensus price target of $113.53, suggesting a potential upside of 10.17%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts plainly believe HealthEquity is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HealthEquity	1 Sell rating(s)	0 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.92
Premier	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

HealthEquity beats Premier on 16 of the 17 factors compared between the two stocks.

How does Premier compare to PACS Group?

PACS Group (NYSE:PACS) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, media sentiment, dividends and analyst recommendations.

In the previous week, PACS Group had 15 more articles in the media than Premier. MarketBeat recorded 17 mentions for PACS Group and 2 mentions for Premier. PACS Group's average media sentiment score of 0.51 beat Premier's score of 0.00 indicating that PACS Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
PACS Group	6 Very Positive mention(s)	1 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Premier	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

PACS Group currently has a consensus target price of $61.33, suggesting a potential upside of 27.30%. Given PACS Group's stronger consensus rating and higher possible upside, equities analysts clearly believe PACS Group is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PACS Group	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Premier	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

74.4% of Premier shares are owned by institutional investors. 70.1% of PACS Group shares are owned by insiders. Comparatively, 1.0% of Premier shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

PACS Group has a beta of -0.14, meaning that its share price is 114% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

PACS Group has a net margin of 4.87% compared to Premier's net margin of -3.28%. PACS Group's return on equity of 31.98% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PACS Group	4.87%	31.98%	6.07%
Premier	-3.28%	6.84%	3.48%

PACS Group has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PACS Group	$5.29B	1.45	$191.54M	$1.77	27.22
Premier	$1.00B	4.03	$20.27M	-$0.27	N/A

Summary

PACS Group beats Premier on 13 of the 16 factors compared between the two stocks.

How does Premier compare to Chemed?

Chemed (NYSE:CHE) and Premier (NASDAQ:PINC) are both mid-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Chemed has a beta of 0.5, suggesting that its share price is 50% less volatile than the broader market. Comparatively, Premier has a beta of 0.64, suggesting that its share price is 36% less volatile than the broader market.

95.9% of Chemed shares are held by institutional investors. Comparatively, 74.4% of Premier shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 1.0% of Premier shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Chemed has a net margin of 10.61% compared to Premier's net margin of -3.28%. Chemed's return on equity of 35.18% beat Premier's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Chemed	10.61%	35.18%	19.43%
Premier	-3.28%	6.84%	3.48%

Chemed pays an annual dividend of $2.80 per share and has a dividend yield of 0.5%. Premier pays an annual dividend of $0.84 per share and has a dividend yield of 1.7%. Chemed pays out 13.4% of its earnings in the form of a dividend. Premier pays out -311.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Chemed has raised its dividend for 16 consecutive years. Premier is clearly the better dividend stock, given its higher yield and lower payout ratio.

Chemed currently has a consensus target price of $603.00, indicating a potential upside of 9.79%. Given Chemed's stronger consensus rating and higher probable upside, equities research analysts plainly believe Chemed is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Chemed	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
Premier	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Chemed has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Chemed	$2.53B	2.83	$265.24M	$20.90	26.28
Premier	$1.00B	4.03	$20.27M	-$0.27	N/A

In the previous week, Chemed had 7 more articles in the media than Premier. MarketBeat recorded 9 mentions for Chemed and 2 mentions for Premier. Chemed's average media sentiment score of 0.77 beat Premier's score of 0.00 indicating that Chemed is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Chemed	4 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Premier	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Chemed beats Premier on 15 of the 19 factors compared between the two stocks.

How does Premier compare to Hims & Hers Health?

Premier (NASDAQ:PINC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, media sentiment, profitability and analyst recommendations.

74.4% of Premier shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 1.0% of Premier shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hims & Hers Health has a consensus price target of $31.53, suggesting a potential upside of 59.59%. Given Hims & Hers Health's stronger consensus rating and higher probable upside, analysts clearly believe Hims & Hers Health is more favorable than Premier.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Premier	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.13

Premier has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.53, indicating that its share price is 153% more volatile than the broader market.

Hims & Hers Health has higher revenue and earnings than Premier. Premier is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Premier	$1.00B	4.03	$20.27M	-$0.27	N/A
Hims & Hers Health	$2.35B	1.96	$128.37M	-$0.83	N/A

Premier has a net margin of -3.28% compared to Hims & Hers Health's net margin of -6.65%. Premier's return on equity of 6.84% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Premier	-3.28%	6.84%	3.48%
Hims & Hers Health	-6.65%	-9.62%	-1.38%

In the previous week, Hims & Hers Health had 69 more articles in the media than Premier. MarketBeat recorded 71 mentions for Hims & Hers Health and 2 mentions for Premier. Premier's average media sentiment score of 0.00 beat Hims & Hers Health's score of -0.19 indicating that Premier is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Premier	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	4 Very Positive mention(s)	13 Positive mention(s)	23 Neutral mention(s)	23 Negative mention(s)	2 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Premier on 9 of the 16 factors compared between the two stocks.

Get Premier News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PINC vs. The Competition

Export

Metric	Premier	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$2.33B	$10.86B	$7.91B	$12.24B
Dividend Yield	2.97%	2.54%	2.46%	4.51%
P/E Ratio	-181.80	38.15	34.34	28.45
Price / Sales	4.03	2.16	8.90	6.00
Price / Cash	9.74	23.62	22.23	22.80
Price / Book	2.65	3.66	4.50	3.83
Net Income	$20.27M	$335.01M	$3.51B	$390.69M

Premier Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PINC Premier	N/A	$49.09 +74.2%	N/A	+74.2%	$2.33B	$1.00B	N/A	2,700	News Coverage
HSIC Henry Schein	2.3525 of 5 stars	$82.86 -4.3%	$93.27 +12.6%	+18.3%	$9.23B	$13.18B	24.16	25,000
HQY HealthEquity	3.6601 of 5 stars	$103.12 -0.5%	$113.53 +10.1%	+2.5%	$8.54B	$1.31B	37.28	2,814
PACS PACS Group	4.6037 of 5 stars	$46.42 +1.8%	$58.80 +26.7%	+321.2%	$7.34B	$5.29B	26.98	47,455	Insider Trade
CHE Chemed	4.2155 of 5 stars	$535.32 -1.3%	$603.00 +12.6%	+22.8%	$7.00B	$2.66B	25.61	15,811	Dividend Announcement

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PINC) was last updated on 11/13/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Premier (PINC) Competitors

PINC vs. HSIC, HQY, PACS, CHE, and HIMS

How does Premier compare to Henry Schein?

Summary

How does Premier compare to HealthEquity?

Summary

How does Premier compare to PACS Group?

Summary

How does Premier compare to Chemed?

Summary

How does Premier compare to Hims & Hers Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Premier (PINC) Competitors

PINC vs. HSIC, HQY, PACS, CHE, and HIMS

How does Premier compare to Henry Schein?

Does the media refer more to HSIC or PINC?

Which has preferable valuation & earnings, HSIC or PINC?

Which has more risk and volatility, HSIC or PINC?

Do institutionals & insiders believe in HSIC or PINC?

Is HSIC or PINC more profitable?

Do analysts rate HSIC or PINC?

Summary

How does Premier compare to HealthEquity?

Do institutionals and insiders hold more shares of HQY or PINC?

Is HQY or PINC more profitable?

Which has more volatility & risk, HQY or PINC?

Does the media favor HQY or PINC?

Which has preferable earnings & valuation, HQY or PINC?

Do analysts recommend HQY or PINC?

Summary

How does Premier compare to PACS Group?

Does the media favor PACS or PINC?

Do analysts prefer PACS or PINC?

Do insiders and institutionals hold more shares of PACS or PINC?

Which has more volatility and risk, PACS or PINC?

Is PACS or PINC more profitable?

Which has stronger valuation & earnings, PACS or PINC?

Summary

How does Premier compare to Chemed?

Which has more risk and volatility, CHE or PINC?

Do insiders and institutionals hold more shares of CHE or PINC?

Is CHE or PINC more profitable?

Is CHE or PINC a better dividend stock?

Do analysts prefer CHE or PINC?

Which has higher earnings and valuation, CHE or PINC?

Does the media prefer CHE or PINC?

Summary

How does Premier compare to Hims & Hers Health?

Do institutionals & insiders believe in PINC or HIMS?

Do analysts rate PINC or HIMS?

Which has more risk and volatility, PINC or HIMS?

Which has better earnings and valuation, PINC or HIMS?

Is PINC or HIMS more profitable?

Does the media prefer PINC or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PINC vs. The Competition

Premier Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools